Recent discovery and development of endothelin receptor antagonists

Author： Wu C.

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.11, 2000-11, pp. : 1653-1668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical development of endothelin receptor antagonists

By Douglas S.A.

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 408-413

Elsevier

Access to resources Recommend Favorite

Blocking of the Endothelin System: The Development of Receptor Antagonists

By Battistini B. Dussault P.

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 2, 1998-04 ,pp. : 97-112

Academic Press

Access to resources Recommend Favorite

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Receptor Antagonists - An Overview

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 549-575

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the discovery of antagonists acting at P2X₇ receptor

By Romagnoli Romeo Baraldi Pier Giovanni Di Virgilio Francesco

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 271-287

Informa Healthcare

Access to resources Recommend Favorite